Marketing was aggressive. The drug was targeted especially to pregnant women, who, given the casual misogyny of the time, were often considered “anxious” and “emotional” and therefore needed to be sedated. Thalidomide was soon approved in forty countries and was being prescribed to tens of thousands of women.
